The absence of the p15INK4B gene alterations in adult patients with precursor B-cell acute lymphoblastic leukaemia is a favourable prognostic factor

British Journal of Haematology

Volumn 117, Issue 3, 2002, Pages 531-540

  Hoshino, Koyu ^a   Asou, Norio ^a   Okubo, Toshiya ^a   Suzushima, Hitoshi ^a   Kiyokawa, Tetsuyuki ^b   Kawano, Fumio ^b   Mitsuya, Hiroaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

Author keywords

Acute lymphoblastic leukaemia; Methylation; p15; p16; Ph chromosome

Indexed keywords

MESSENGER RNA; PROTEIN P15; PROTEIN P16; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN P16INK4A; RNA; TUMOR MARKER; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; FEMALE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STEM CELL; SURVIVAL TIME; WILD TYPE; DISEASE FREE SURVIVAL; GENE DELETION; GENE EXPRESSION; GENETICS; MIDDLE AGED; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, SOUTHERN; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE-FREE SURVIVAL; DNA METHYLATION; FEMALE; GENE DELETION; GENE EXPRESSION; GENES, P16; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA, B-CELL, ACUTE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0036000273     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03451.x     Document Type: Article

References (43)

1. Extensive intra- and inter individual heterogeneity of p15INK4B methylation in acute myeloid leukemia
2. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia
3. Frequent methylation silencing of p15 (INK4b) (MTS2) and p16 (INK4a) (MTS1) in B-cell and T-cell lymphomas
4. Proposals for the classification of the acute leukaemias
5. TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors
6. p15 (INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing
7. The biology and treatment of acute lymphoblastic leukemia in adults
8. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in hematological disorders
9. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
10. Methylation of the 5′-CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
11. The human beta 2-micro-globulin gene. Primary structure and definition of the transcriptional unit
12. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest
13. Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemia
14. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B
15. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
16. Distinct patterns of inactivation of p15INK4B and p16 INK4A characterize major types of hematological malignancies
17. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults
18. Improved outcome in adult B-cell acute lymphoblastic leukemia
19. TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation
20. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia
21. A cell regulator potentially involved in genesis of many tumor types
22. Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia
23. Acquisition of p16 (INK4A) and p15 (INK4B) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia
24. 5′-CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers
25. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia
26. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin
27. Deletions of the cyclin dependent kinase-4 inhibitor gene in multiple cancers
28. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies
29. Myelomonoblastic leukaemia cells carrying the PEBP2β/MYH11 fusion gene are CD34, c-KIT+ immature cells
30. Biallelic and heterozygous point mutations in the Runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemia
31. INK4B/MTS2 in human leukemias and lymphomas
32. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia
33. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression
34. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM group
35. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia
36. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
37. Inhibitor of mammalian G1 cycline-depedent kinases
38. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis
39. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: The JALSG-ALL93 study
40. Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: The ALL-87 study of the Japan Adult Leukemia Study Group (JALSG)
41. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes
42. Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: The ALL90 study of the Japan Adult Leukemia Study Group (JALSG)
43. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: Potential prognostic implications